Table 1 Clinicopathological characteristics of ESCC patients in training and test set.
Characteristics | Training set(n = 180) | Test set(n = 78) | P value |
|---|---|---|---|
Age, median [IQR] | 64.50(59.00–71.00) | 64.50(59.00–70.00) | 0.941 |
Gender, n (%) | 0.388 | ||
Female | 57(31.67) | 29(37.18) | |
Male | 123(68.33) | 49(62.82) | |
Neutrophil, median [IQR] | 3.99 (3.01–5.24) | 4.19 (3.28–5.67) | 0.315 |
Lymphocyte, median [IQR] | 1.29(1.04–1.57) | 1.30(1.10–1.72) | 0.273 |
Monocyte, median [IQR] | 0.36(0.28–0.51) | 0.36 (0.29–0.48) | 0.859 |
Platelet, median [IQR] | 199.00(152.00-237.25) | 229.00(165.00-268.75) | 0.056 |
NLR, median [IQR] | 3.04(2.09–4.16) | 3.05(2.01–4.91) | 0.914 |
PLR, median [IQR] | 148.44(113.52-202.36) | 156.39(115.11-215.73) | 0.548 |
LMR, median [IQR] | 3.58 (2.56–4.89) | 3.54 (2.36–5.27) | 0.608 |
SII, median [IQR] | 577.25(409.01-944.02) | 649.10(385.45-1037.41) | 0.349 |
Location, n (%) | 0.492 | ||
Upper | 31 (17.22) | 9(11.54) | |
Middle | 90(50.00) | 43(55.13) | |
Lower | 59(32.78) | 26(33.33) | |
Differentiation, n (%) | 0.100 | ||
Well | 47(26.11) | 11(14.10) | |
Moderately | 102(56.67) | 50(64.10) | |
Poorly | 31(17.22) | 17(21.79) | |
pT stage, n (%) | 0.264 | ||
T1 | 18(10.00) | 5(6.41) | |
T2 | 42(23.33) | 23(29.49) | |
T3 | 118(65.56) | 47(60.26) | |
T4 | 2(1.11) | 3(3.85) | |
pN stage, n (%) | 0.405 | ||
N0 | 80(44.44) | 39(50.00) | |
N1 | 65(36.11) | 21(26.92) | |
N2 | 23(12.78) | 14(17.95) | |
N3 | 12(6.67) | 5(6.41) | |
LVI, n (%) | 0.136 | ||
No | 95(52.78) | 49(62.82) | |
Yes | 85(47.22) | 29(37.18) | |
PNI, n (%) | 0.765 | ||
No | 152(84.44) | 67(85.90) | |
Yes | 28(15.56) | 11(14.10) | |
Radscore, median [IQR] | -0.11[-0.90-0.72] | -0.27[-1.09-0.22] | 0.220 |
